Teladoc Health Reports Fourth-Quarter and Full-Year 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Teladoc (TDOC) PT Lowered to $70 at Cantor Fitzgerald
February 28, 2019 9:00 AM ESTCantor Fitzgerald analyst Steven Halper lowered the price target on Teladoc (NYSE: TDOC) to $70.00 (from $83.00) while maintaining a Neutral rating following the company's 4Q earnings report. Revenue was $123M vs. consensus of $120M. Adjusted EBITDA was $5.8M vs. $2.4M a year... More
